Acer Therapeutics Inc. Gains 35.67%
Fri, Dec 09, 2022 at 06:58 PM
Acer Therapeutics Inc. (ACER:NASDAQ) shot up at $2.13, a gain of 35.7%. On Fri, Dec 09, 2022, ACER:NASDAQ hit a New 2-Week High of $2.13. The stock got featured on our News Catalysts scanner on Fri, Dec 09, 2022 at 03:07 AM in the 'BIOTECH' category. From Fri, Nov 25, 2022, the stock recorded 60.00% Up Days and 72.73% Green Days
About Acer Therapeutics Inc. (ACER:NASDAQ)
Acer Therapeutics Inc is a pharmaceutical company that acquires, develops and intends to commercialize therapies for patients with serious rare diseases with critical unmet medical need.
Top 10 Gainers:
- Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE), 1007.59%
- HTG Molecular Diagnostics, Inc. (HTGM:NASDAQ), 117.57%
- ClearOne, Inc. (CLRO:NASDAQ), 73.4%
- China Jo-Jo Drugstores, Inc. (CJJD:NASDAQ), 53.24%
- Hillstream BioPharma Inc. (HILS:NASDAQ), 43.41%
- Rockley Photonics Holdings Limited (RKLY:NYSE), 40.39%
- Cardiol Therapeutics Inc. (CRDL:NASDAQ), 38.3%
- PainReform Ltd. (PRFX:NASDAQ), 37.21%
- Advanced Human Imaging Limited. (AHI:NASDAQ), 35.97%
- Acer Therapeutics Inc. (ACER:NASDAQ), 35.67%